Merck shares rise after Barclays upgrades shares, downgrades competitor Pfizer
April 05, 2018 at 08:47 AM EDT
Barclays upgraded Merck to overweight from equal weight on better opportunities versus its competition, while downgrading Pfizer to equal weight from overweight given the less likely chance of a "transformative" acquisition.